Aptar Pharma is pleased to announce that its portable, patented PureHale™ respiratory device is the delivery system behind Blairex Laboratories’ new Breathe Free® Essentials brand, launched exclusively on Amazon.com.
This marks the first commercial launch worldwide of a brand using Aptar Pharma’s innovative PureHale™ respiratory technology.
Breathe Free® Essentials is formulated with moisturizing saline and 100% natural essential oils, and is available in three blends – Soothing, Relaxing and Clarity. Each Breathe Free® Essentials kit comes with a personal face mask and adapter for effortless, on-the-go delivery for today’s in-demand lifestyle.
Aptar Pharma’s PureHale™ is a portable and ready-to-use delivery solution designed for upper respiratory care. An alternative to traditional nebulizer technology, PureHale™, when used with saline and other natural ingredients, distributes a fine, gentle mist to cleanse, moisturize and soothe the upper respiratory tract, in turn helping to reduce any irritations caused by coughs, colds, allergies, respiratory problems and dry nose/throat issues.
PureHale’s user-friendly system is based on Aptar Pharma’s well-established Bag-on-Valve technology which, when actuated, delivers a continuous mist with fine particles of approximately 20µm optimized for targeted deposition to the upper airways. Unlike traditional nebulizers, the PureHale™ system does not require batteries or the prefilling of a reservoir. Both quiet and lightweight, the device can be used with or without a mask, offering adaptable treatment options.
Jeffrey Logston, President, Blairex Laboratories, Inc., “Blairex Laboratories has a history of offering products in innovative packaging and delivery systems. Breathe Free® Essentials continues that legacy. We designed Breathe Free® Essentials to create an on-the-go personal retreat, and hope to provide our customers with a much needed moment to breathe.”
“We are pleased to partner with Blairex on this first launch of our PureHale™ device with Breathe Free® Essentials,” commented Gael Touya, President of Aptar Pharma. “PureHale’s innovative technology is meeting a new need in the marketplace for portable, on-the-go respiratory support. We look forward to this and future launches using PureHale™.”